Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial). - Hanrath MA; Banken E; van den Wildenberg SAH; van de Kerkhof D; Moes DJAR; Boisdron-Celle M; van den Bosch BJC; Bax R; Bet PM; Maring JG; Creemers GM; van Hellemond IEG; et al. (Cancer chemotherapy and pharmacology, 2025)